Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 17;110(7):e2309-e2316.
doi: 10.1210/clinem/dgaf017.

Approach to the Patient with Achondroplasia-New Considerations for Diagnosis, Management, and Treatment

Affiliations
Review

Approach to the Patient with Achondroplasia-New Considerations for Diagnosis, Management, and Treatment

Nadia Merchant et al. J Clin Endocrinol Metab. .

Abstract

Achondroplasia is the most common disproportionate short-stature skeletal dysplasia. Features associated with achondroplasia are rhizomelia, macrocephaly, midface hypoplasia, and typical cognition. Potential medical complications include foramen magnum stenosis, hydrocephalus, middle ear dysfunction, obstructive and central sleep apnea, spinal stenosis, and genu varum. Recently, vosoritide, a C-type natriuretic peptide analogue, was approved by the Food and Drug Administration with the primary indication of increasing linear growth in all children with achondroplasia and open growth plates. Due to this, pediatric endocrinologists suddenly are encountering infants and children with achondroplasia in their clinic whose families are seeking treatment with vosoritide. There is an urgent need to provide practical guidance pertaining to the diagnosis, management, and surveillance of these patients. Specific to current clinical use of vosoritide and other growth-modulating therapies in development for patients with achondroplasia, it is important to recognize that 1. some children and their families do not automatically desire such treatment, 2. not all treated children exhibit a response in linear growth, and 3. treatment does not negate the necessity of actively surveilling for the potential complications of achondroplasia that are part of its natural history. The goal of this paper is to provide probable, contemporary clinical scenarios of infants and children with achondroplasia who may present to an endocrinologist. This information is especially crucial to the endocrinologist when there is no specialized skeletal dysplasia center near the family.

Keywords: CNP; achondroplasia; foramen magnum stenosis; skeletal dysplasia; vosoritide.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Complications at different stages of life in patients with achondroplasia.
Figure 2.
Figure 2.
Features for clinical suspicion of achondroplasia after birth. A, Deviation between the third and fourth digits (“trident hands”). B, Decreased interpedicular distance from upper to lower lumbar spine. C, Flat rounded iliac bones with narrow sacrosciatic notches, and radiolucency of the proximal femurs. Consent obtained from patient.

References

    1. Hoover-Fong J, Scott CI, Jones MC; Committee On Genetics . Health supervision for people with achondroplasia. Pediatrics. 2020;145(6):e20201010. - PubMed
    1. Hoover-Fong J, Cheung MS, Fano V, et al. Lifetime impact of achondroplasia: current evidence and perspectives on the natural history. Bone. 2021;146:115872. - PubMed
    1. Foreman PK, van Kessel F, van Hoorn R, van den Bosch J, Shediac R, Landis S. Birth prevalence of achondroplasia: a systematic literature review and meta-analysis. Am J Med Genet A. 2020;182(10):2297‐2316. - PMC - PubMed
    1. Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet. 2007;370(9582):162‐172. - PubMed
    1. Merchant N, Polgreen LE, Rosenfeld RG. What is the role for pediatric endocrinologists in the management of skeletal dysplasias? J Clin Endocrinol Metab. 2024;109(5):e1410‐e1414. - PMC - PubMed

Substances